Windlas Biotech Ltd posts QoQ fall in Q1FY23 consolidated profit to Rs. 9.8 crores

Windlas Biotech Ltd has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 122.794 crores during the period ended June 30, 2022 as compared to Rs. 125.136 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. 9.80 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 14.788 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. 4.50 for the period ended June 30, 2022 as compared to Rs. 6.97 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 122.794 crs	₹125.136 crs	-1.87%
Net Profit	₹9.80 crs	₹14.788 crs	-33.73%
EPS	₹4.50	₹6.97	-35.44%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 122.794 crores during the period ended June 30, 2022 as compared to Rs.111.645 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.9.80 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.6.687 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.4.50 for the period ended June 30, 2022 as compared to Rs.3.67 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 122.794 crs	₹111.645 crs	9.99%
Net Profit	₹9.80 crs	₹6.687 crs	46.55%
EPS	₹4.50	₹3.67	22.62%

Shares of Windlas Biotech Ltd was last trading in BSE at Rs. 223.55 as compared to the previous close of Rs. 228.55. The total number of shares traded during the day was 1161 in over 164 trades.

The stock hit an intraday high of Rs. 230.00 and intraday low of 223.00. The net turnover during the day was Rs. 261566.00.

Source : Equity Bulls

Keywords

WindlasBiotech Q1FY23 ResultUpdate